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Abstract
Functional expression of sweet taste receptors (T1R2 and T1R3) has been reported in numerous metabolic tissues, including
the gut, pancreas, and, more recently, in adipose tissue. It has been suggested that sweet taste receptors in these non-
gustatory tissues may play a role in systemic energy balance and metabolism. Smaller adipose depots have been reported in
T1R3 knockout mice on a high carbohydrate diet, and sweet taste receptors have been reported to regulate adipogenesis in
vitro. To assess the potential contribution of sweet taste receptors to adipose tissue biology, we investigated the adipose
tissue phenotypes of T1R2 and T1R3 knockout mice. Here we provide data to demonstrate that when fed an obesogenic
diet, both T1R2 and T1R3 knockout mice have reduced adiposity and smaller adipocytes. Although a mild glucose
intolerance was observed with T1R3 deficiency, other metabolic variables analyzed were similar between genotypes. In
addition, food intake, respiratory quotient, oxygen consumption, and physical activity were unchanged in T1R2 knockout
mice. Although T1R2 deficiency did not affect adipocyte number in peripheral adipose depots, the number of bone marrow
adipocytes is significantly reduced in these knockout animals. Finally, we present data demonstrating that T1R2 and T1R3
knockout mice have increased cortical bone mass and trabecular remodeling. This report identifies novel functions for
sweet taste receptors in the regulation of adipose and bone biology, and suggests that in these contexts, T1R2 and T1R3 are
either dependent on each other for activity or have common independent effects in vivo.
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Introduction
Sweet taste perception by the tongue is mediated by the G
protein-coupled receptors T1R2 and T1R3 [1,2]. These receptors
are reported to function as obligate heterodimers to provide input
on the caloric and macronutrient content of ingested food.
However, sweet taste receptors have been identified in an
increasing number of extra-gustatory tissues [3–7], often regulat-
ing metabolic processes [8–13]. In pancreatic b-cells, sweet taste
receptors act to augment glucose-induced insulin secretion in
response to artificial sweeteners [11] and fructose [13]. In
addition, mice lacking gustducin, a mediator of taste receptor
signaling, have reduced glucagon-like peptide-1 (GLP-1) and
insulin secretion on account of the loss of sweet taste receptor
activity in GLP-1-secreting enteroendocrine cells of the gut [12].
However, sweetener-stimulated GLP-1 secretion appears to be
dependent on T1R3, but not T1R2 expression [14], suggesting
that these receptors may also function independently of each other
in some contexts, perhaps as homodimers.
In addition to effects on insulin and incretin secretion [10,13],
sweet taste receptors may also have metabolic roles in adipose
tissue. Masubuchi et al reported that T1R2 and T1R3 are
expressed in 3T3-L1 cells, and that T1R3 is induced during
differentiation and mediates inhibition of adipogenesis by artificial
sweeteners [15]. Our group also observed that T1R2 and T1R3
are expressed throughout adipogenesis; however, in our hands,
saccharin and acesulfame potassium enhance adipogenesis and
suppress adipocyte lipolysis through a mechanism independent of
both T1R2 and T1R3 [16]. An additional study has shown that
T1R3 knockout (KO) animals are resistant to sucrose-induced
obesity and have smaller fat depots on a high-sucrose diet [17],
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consistent with roles for sweet taste receptors in facilitating adipose
tissue expansion. Given that T1R2 and T1R3 are expressed in
adipose tissues [16] and have known metabolic functions in other
tissues [11–14], we performed comprehensive metabolic pheno-
typing of T1R2 and T1R3 KO mice to further clarify the potential
developmental and metabolic roles of sweet taste receptors in vivo.
In this report, we investigate the contribution of sweet taste
receptors to adipose tissue and metabolic homeostasis by
characterizing T1R2 and T1R3 KO mice on a westernized diet.
We demonstrate that both KO genotypes show a reduction in
adiposity and adipocyte size following this dietary intervention.
Despite the reduced adipose tissue expansion in taste receptor KO
mice, we detected no or mild changes in glucose tolerance, insulin
sensitivity, and energy balance. However, we observed that taste
receptor KO reduces adipocyte number in the bone marrow
compartment, and increases cortical bone mass and trabecular
remodeling. These data represent the first demonstration and
comparison of adipose tissue and bone phenotypes in T1R2 and
T1R3 KO animals, and this study thereby provides valuable
insight into the shared and independent functions of sweet taste
receptors in vivo.
Materials and Methods
Animal Care and Maintenance
T1R2 and T1R3 KO animals were obtained from Bjo¨rn
Tyrberg (Sanford-Burnham Medical Research Institute, Lake
Nona, FL), and originally developed by [2] (Charles Zuker;
Columbia University, NY). Mice had been backcrossed to 90–95%
congenicity with C57BL/6J and were then further backcrossed up
to four generations. All experiments were performed on male
animals maintained on Western Diet (D12079B, Research Diets,
New Brunswick NJ). All mice were housed on a 12-hour light/12-
hour dark cycle in the Unit for Laboratory Animal Medicine
(ULAM) at the University of Michigan, with free access to food
and water. Procedures for this work were approved by the
Committee on the Use and Care of Animals at the University of
Michigan, with daily care of animals overseen by the Unit for
Laboratory Animal Medicine (PRO0001369).
Animal Measurements
Blood glucose levels were measured with an automated blood
glucose reader (Accu-Check, Roche Diagnostics, Indianapolis, IN).
Body fat, lean mass, and free fluid were measured in conscious
animals using an NMR analyzer (Minispec LF9011, Brucker
Optics, Billerica MA) in the phenotyping core of the Nutrition
Obesity Research Center at the University of Michigan. Oxygen
consumption (VO2), carbon dioxide production (VCO2), sponta-
neous motor activity and food intake were measured using the
Oxymax Comprehensive Lab Animal Monitoring System
(CLAMS, Columbus Instruments; Columbus OH), an integrated
open-circuit calorimeter equipped with an optical beam activity-
monitoring device. The measurements were carried out continu-
ously for 72 h. During this time, animals were provided free access
to food and water through the equipped feeding and drinking
devices located inside the chamber. Respiratory quotient (RQ) was
calculated as VCO2/VO2.
Adipocyte Histomorphometry
Adipocyte size and number were calculated from hematoxylin
and eosin stained adipose tissues using MetaMorph Image
Analysis software as previously described [18]. Briefly, 100–
500 mg of the indicated WAT depots were weighed, placed into
2.5 mL tubes and covered with 10% buffered formalin for at least
three days. Prior to paraffin fixation, samples were removed from
formalin and placed in 70% ethanol for 48 h. A Leica 2155 rotary
paraffin microtome was used to make 5 mm sections at 100 mm
intervals across the sample. Samples were then stained and
representative photos taken with a Zeiss inverted microscope at
40X objective. After digital processing, adipocyte cross-sectional
areas were quantified using MetaMorph Microscopy Automation
and Image Analysis software (Molecular Devices, Sunnyvale, CA).
Glucose Tolerance
Mice were fasted for 16 hours with free access to water. Each
mouse was then weighed and glucose measured from tail blood
with Accu-Chek Aviva Glucometer (Roche). After obtaining
baseline glucose measurements, each mouse was then injected
intraperitoneally with a sterile solution of D-glucose at 1 mg/kg.
Blood glucose measurements were then taken from tail bleeds for
each animal at 15, 30, 60, 90 and 120 minutes.
Insulin Tolerance
Mice were fasted for 6 hours with free access to water. Each
mouse was then weighed and glucose measured from tail blood
with Accu-Chek Aviva Glucometer (Roche). After obtaining
baseline glucose measurements, each mouse was then injected
intraperitoneally with a sterile solution of insulin at 0.75 U/kg.
Blood glucose measurements were then taken from tail bleeds for
each animal at 15, 30, 60, 90 and 120 minutes.
Insulin Measurements
Insulin was measured from serum obtained 30 minutes
following glucose injection using an ELISA kit (Crystal Chem,
Downer’s Grove, IL) and following manufacturer’s instructions.
Food Intake
Food dispensed into animal cages was initially weighed, and
subsequently reweighed every 7 days for 5 weeks. After sifting from
animal bedding, collected food wastage was weighed and taken
into account when estimating cumulative food consumption.
Osmium Staining
BM adipocytes were labeled with osmium tetroxide as follows:
bones were decalcified for 14 days in 14% EDTA, pH7.4, then
washed for 3610 min in PBS or Sorensen’s Phosphate buffer, pH
7.4, before staining bones in 1% osmium tetroxide for 24 h. Bones
were then washed again 364–6 h in Sorensen’s Phosphate buffer,
pH 7.4, before re-scaning bones with mCT as described below.
The tibia/fibula junction was identified and the number of slices
between the tibia/fibula junction and the growth plate in the same
bone prior to decalcification was determined. This number was
subtracted to identify the growth plate on the osmium scan. We
then used a threshold of 400 to quantify the marrow fat (excluding
any fat in attached tissues) between the growth plate and tibia/
fibula junction on the osmium-stained bone. Decalcification,
osmium staining and wash steps were done at room temperature.
mCT Scanning
Mouse specimens were embedded in 1% agarose and scanned
using a microCT system. Agarose-embedded mouse bones were
placed in a 19 mm diameter tube prior to scanning the length of
the bones using the following settings: voxel size 12 mm, medium
resolution, 70 kVp, 114 mA, 0.5 mm AL filter, and integration
time 500 ms. Density measurements were calibrated to the
manufacturer’s hydroxyapatite phantom. Analysis was performed
using the manufacturer’s evaluation software. Mouse cortical bone
Metabolic Phenotyping of T1R2 and T1R3 KO Mice
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was analyzed with a threshold of 280, as follows: 1, the growth
plates and tibia/fibula junction were identified and the distance in
slices between the two calculated; 2, 70% of this distance was
calculated and added to the growth plate landmark; 3, contour at
this slice; 4, contour 30 slices up from this initial slice; 4, iterate
between these two contours using an outer value of 0 and an inner
value of 280, using the stop button to stop. Mouse trabeculae were
analyzed using a threshold of 180, as follows: 1, identify the growth
plate and go down five slices; 2, draw an internal outline every 10
slices for 50 slices; 3, back-calculate using an outer value of 272
and an inner value of 0. The total volume of mouse bones was
determined by contouring around the entire bone between the
growth plate and tibia/fibula junction, and then calculating the
bone volume and total volume using a threshold of 220.
Results
T1R3 KO mice have reduced adiposity on Western Diet
Because T1R2/T1R3 function as carbohydrate sensors in the
gut and pancreas [12], we hypothesized that sweet taste receptors
would serve as mediators of ‘positive’ nutrient signals derived from
binding taste receptor ligands in adipose tissue. We therefore
anticipated that mice lacking sweet taste receptors might show
impairment of adipogenesis or anabolic processes, or have reduced
repression of catabolic processes such as lipolysis. Together these
deficiencies might lead to metabolic dysfunction. Thus, to assess
effects of sweet taste receptor KO on adiposity, we subjected WT
and T1R3 KO mice to a 24-week Western diet challenge (41%
kcal fat, 43% kcal protein, 17% kcal protein, high sucrose and high
cholesterol). At the end of this treatment, body weight did not
differ between genotypes (Fig. 1A). However, when the body
composition of these animals was evaluated, we observed that
T1R3 KO animals had reduced fat mass and increased lean mass
as percent of body weight (Fig. 1B). Absolute fat mass was also
reduced, though absolute lean mass was not statistically different
(Fig. 1C).
To further characterize differences in adiposity in T1R3 KO
animals, we measured the weight of individual fat depots (Fig. 1D).
However, we observed no differences in the weights of inguinal,
epididymal, or perirenal fat depots. There was also no change in
liver or brown adipose tissue weight. This disparity between whole
body adiposity and weight of individual adipose tissues could be due
to greater differences in adipose depots that were not isolated;
accumulation of lipid outside of adipose tissue; or result from the
amalgamation of small changes within many individual fat pads.
The trend towards reduced weight in all KO adipose tissues suggests
that the latter might be the case. Taken together, these data are
supportive of a role for T1R3 in regulating adiposity in vivo.
Adipose tissue from T1R3 KO mice on Western diet has
smaller and more numerous adipocytes
Reduced adiposity in T1R3 KO animals could be due to
decreased adipocyte number, smaller adipocyte size, or both. To
Figure 1. T1R3 KO mice have reduced adiposity on Western Diet. A) Body weight in WT and T1R3 KO animals after 24 weeks of
Western Diet. Fat mass and lean mass as percent of body weight B) or in absolute mass C) measured by NMR in WT (n = 7) and T1R3 KO (n= 8)
animals after 24 weeks Western Diet. D) Weight of inguinal, epididymal, or perirenal fat pads, liver, and brown adipose tissue (BAT) following 24
weeks of Western Diet feeding. In each panel, data are expressed as mean plus S.D. Significance was determined using an unpaired Student’s t-test. P
,0.05 indicated with #.
doi:10.1371/journal.pone.0086454.g001
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determine if T1R3 is a regulator of hyperplasia or hypertrophy we
measured the cross-sectional areas of adipocytes in epididymal
adipose tissue of WT and T1R3 KO mice. We found that the
T1R3 KO animals had a shift towards smaller adipocytes (Fig.
2A), and thus the proportion of large adipocytes was significantly
reduced (Fig. 2B). To further explore this observation and estimate
relative adipocyte numbers between genotypes, we correlated
average adipocyte volume with adipose depot weight for each
animal. A weak trend towards a flatter slope, with intercepts
statistically different (Fig. 2C), suggests adipose depots from T1R3
mice are characterized by smaller and slightly more numerous
adipocytes, especially in those animals with larger adipose depots.
T1R3 KO mice have mild reductions in glucose sensitivity
Given the smaller adipocytes present in T1R3 KO mice, we
hypothesized that these animals might have altered glucose
tolerance. To test this, we first measured blood glucose from
WT and T1R3 KO animals that had been fasted for 16 h (Fig 3A).
However, we observed no difference between genotypes. We next
evaluated the glucose tolerance of T1R3 KO animals by
performing intraperitoneal glucose tolerance tests (IP GTT) in
WT and T1R3 KO mice after 24 weeks of Western diet (Fig 3B).
We observed no significant differences between WT and T1R3
KO mice at any time point following glucose injection (Fig. 3B left
panel); however, the area under the curve (AUC) of GTTs from
T1R3 KO animals was significantly greater due to small changes
in glucose excursion at each time point (Fig. 3B, right panel). Thus,
T1R3 KO mice may be mildly glucose intolerant, although fasting
glucose was not different between genotypes (Fig. 3A). Elevated
blood glucose concentrations are not due to reduced insulin
secretion in response to glucose load, as serum insulin did not
differ between genotypes 30 min following glucose injection (Fig
3C). To determine if insulin sensitivity was reduced in T1R3 KO
animals, we next performed an intraperitoneal insulin tolerance
test (ITT, Fig 3D). However, these animals showed no difference
in this measure of insulin sensitivity at individual time points (left
panel) or in AUC (right panel). Consistent with the mild change in
glucose sensitivity observed in T1R3 KO animals, random fed
glucose concentrations were also not different (Fig 3E). Given the
smaller adipocytes present in T1R3 KO mice, we next hypoth-
esized that these animals might have elevated rates of lipolysis. To
test this, we measured fed and fasted serum NEFA concentrations
in WT and T1R3 KO animals; however, we did not observe
alterations in serum NEFA in either random fed animals (Fig 3F)
or those fasted for 16 h (Fig 3F). Serum glycerol concentrations
were also similar between genotypes (unpublished data).
T1R2 KO mice have reduced adiposity on Western Diet
We continued our investigation of sweet taste receptor functions
in adipose tissue by examining the adiposity of T1R2 KO mice
upon a Western diet challenge. As T1R2 and T1R3 are generally
believed to be obligate heterodimers [1,2] with both receptors
required for function, we predicted that T1R2 KO animals would
mirror the phenotypes of T1R3 deficiency. We therefore placed
Figure 2. T1R3 KO mice on a Western diet have fewer large adipocytes but increased adipocyte number. A) The frequency distribution
reveals that adipocyte sizes in epididymal adipose tissue from WT (n= 7) and T1R3 KO (n= 8) mice on a Western diet are shifted towards smaller cells.
B) T1R3 KO animals have decreased frequency of large adipocytes, defined as having a surface area greater than 7500 mm2, relative to WT animals.
Significance was determined using Student’s t-test. P ,0.05 indicated with #. Data are expressed as mean plus S.D. C) Linear relationship between
eWAT (epididymal white adipose tissue) weight and average adipocyte volume for WT (r2 = 0.71) and T1R3 KO (r2 = 0.94) mice. Slope (P = 0.14) and
intercept (P , 0.05).
doi:10.1371/journal.pone.0086454.g002
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adult T1R2 KO animals on Western diet and evaluated effects on
body composition. T1R2 KO animals were heavier than WT
controls at the start of the experiment, but after 14 weeks of
Western diet there was no significant difference in body weight
(Fig. 4A). However, both relative and absolute fat mass were
reduced in T1R2 KO mice after 5 weeks of dietary challenge, and
this persisted for the remainder of the experiment (Fig. 4B, C).
Likewise, lean mass was also increased (Fig. 4D, E). Examining
individual adipose depots to further characterize loss of adiposity,
we observed that several adipose tissue depots were significantly
lighter following the Western diet (Fig. 4F). These data are
consistent with the leaner body composition observed in T1R3
KO animals, thus supporting a model whereby the T1R2/T1R3
heterodimer regulates adiposity.
T1R2 KO mice have smaller adipocytes but equal
adipocyte numbers
As the reduced adiposity in T1R2 KO mice mirrored that of
T1R3 KO animals, we investigated whether adipocyte size was
similarly altered between genotypes. Frequency analysis of
adipocyte size in WT and T1R2 KO epididymal fat depots
revealed a shift towards smaller adipocytes (Fig. 5A), as observed
in T1R3 KO animals. Indeed, T1R2 KO animals had a
significantly greater proportion of small adipocytes and a
significantly lower proportion of large adipocytes (Fig. 5B). Finally,
we again estimated relative adipocyte number between genotypes
by correlating average adipocyte volume with fat depot weight
using linear regression (Fig. 5C). In T1R2 KO adipose, there was
no difference between slopes or intercepts in these correlations,
suggesting that reduction in adipose tissue weight is accounted for
by smaller adipocytes, rather than fewer adipocytes. Accordingly,
the phenocopying of reduced adipocyte size between T1R2 and
T1R3 KO mice supports a role for a heterodimeric T1R2/T1R3
sweet taste receptor regulating adipose tissue biology.
T1R2 KO mice have no changes in glucose sensitivity
As KO of T1R2 results in smaller fat depots and smaller
adipocytes, we hypothesized that T1R2 KO animals, like T1R3
KO, may have impaired glucose tolerance. We therefore
measured blood glucose in WT and T1R2 KO animals following
a 16 h fast (Fig 6A), but observed no difference between genotypes.
We next evaluated glucose tolerance by performing an IP GTT;
Figure 3. Glucose tolerance is mildly impaired and insulin sensitivity is similar between WT and T1R3 KO mice. A) Fasted glucose of
WT (n = 6) and T1R3 KO (n= 9) mice. B) IP GTT in WT (n = 6) and T1R3 KO (n= 9) mice on Western Diet for 23 weeks. Time course following glucose
injection (left panel) and AUC (right panel). C) Serum insulin 30 min following glucose injection during IP GTT. D) Intraperitoneal insulin tolerance test
(left panel) in WT (n = 6) and T1R3 KO (n= 8) mice on Western diet for 23.5 weeks. Quantification of AUC (right panel). E) Random fed glucose from WT
(n = 6) and T1R3 KO (n = 9) mice on Western Diet for 24 weeks. F. Random fed NEFA from WT (n= 6) and T1R3 KO (n = 9) mice on Western Diet for 24
weeks. G. Serum NEFA from WT (n= 6) and T1R3 KO (n = 9) mice on Western Diet for 23 weeks, fasted for 16 h. For each panel, data are expressed as
mean plus S.D. Significance was determined using an unpaired Student’s t-test. P ,0.01 indicated with ##.
doi:10.1371/journal.pone.0086454.g003
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however, there was no difference in blood glucose at individual
time points (Fig 6B), AUC (unpublished data), or serum insulin 30
min after glucose injection (Fig 6C). Further, we also observed no
differences in random fed glucose (Fig 6D). We next measured
circulating NEFA concentrations, as reduced adipocyte size could
reflect increased lipolysis. However, as with T1R3 KO (Fig. 3A),
T1R2 KOs showed no difference in serum NEFA under random-
fed conditions (Fig. 6E) or 16 h fasted conditions (Fig 6F).
To investigate other potential mechanisms for reduced adiposity
in T1R2 KO mice, we measured energy balance, carbohydrate
and lipid utilization, and physical activity in T1R2 KO animals.
However, after phenotyping mice with the Comprehensive Animal
Monitoring System (CLAMS), we observed no differences in
respiratory quotient (Fig. 6G), physical activity (Fig. 6H), or rate of
oxygen consumption (unpublished data). Although neither daily
nor cumulative food intake differed (Fig. 6I), serum concentrations
of the adipocyte-derived hormone, adiponectin, were slightly
reduced in serum of T1R2 KO mice (unpublished data).
T1R2 KO mice have fewer bone marrow adipocytes
Lack of T1R2 or T1R3 results in reduced adiposity and smaller
adipocytes in peripheral adipose tissue depots. However, these are
not the only metabolically important adipocyte populations; bone
marrow adipocytes are emerging as an increasingly important
regulator of metabolism [19,20]. We therefore examined adipo-
cyte populations in the bone marrow cavity of T1R2 KO mice by
osmium tetroxide staining [21–23]. Interestingly, mCT scans of
osmium-stained tibiae showed a reduction in the number of bone
marrow adipocytes in KO animals (Fig. 7A). Quantification of this
staining confirmed that adipose tissue volume in bone marrow of
proximal tibiae was significantly reduced in T1R2 KO animals
(Fig. 7B). This was further verified by histological analysis, in
which fewer bone marrow adipocytes were observed in osmium-
stained sections of T1R2 KO tibiae (Fig. 7C). These observations
suggest that lack of T1R2 may impair adipogenesis in the bone
marrow microenvironment.
T1R3 KO animals trend towards fewer bone marrow
adipocytes
To comprehensively assess the contribution of taste receptors to
adipocyte number in the bone marrow compartment, we also
quantified bone marrow adipocytes in T1R3 KO animals. Here
we observed a trend towards reduced numbers of adipocytes in the
media tibia (P = 0.17), but this effect was not significant
Figure 4. T1R2 KO mice have reduced adiposity on Western Diet. A) Body weight in WT (n = 9) and T1R2 KO (n= 9) mice on Western Diet for
14 weeks. B) Fat as percent of body weight or C) as mass. D) Lean mass as percent of body weight or E) as mass in WT and T1R2 KO animals. F)
Adipose depot and liver weights following Western diet feeding. Data are expressed as mean and S.D. Significance was determined using an
unpaired Student’s t-test. P ,0.05 indicated with #.
doi:10.1371/journal.pone.0086454.g004
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(unpublished data). These results suggest a stronger regulatory role
for T1R2 than T1R3 for bone marrow adipogenesis.
T1R2 KO animals have increased trabecular bone mineral
content and cortical area
Our data indicate that loss of T1R2 and T1R3 in the bone
marrow cavity may inhibit adipogenesis. As osteogenesis and
adipogenesis are often reciprocally regulated [24–28], we evalu-
ated the bone mass of these animals to determine if osteogenesis
was increased. We performed mCT scans of WT and T1R2 KO
mouse tibiae to assess the quantity and architecture of cortical and
trabecular bone. We observed that T1R2 KO animals on Western
diet had increased trabecular area (Fig. 8A) and trabecular bone
mineral content (BMC, Fig. 8B). This combination results in very
little change in trabecular bone mineral density (BMD, Fig. 8C), as
greater BMC is diffused over the larger trabecular area.
Differences were not observed in BV/TV, trabecular thickness,
number, or separation (unpublished data). We also observed
alterations in cortical bone; T1R2 KO animals showed an increase
in cortical area (Fig. 8D), but no change in cortical BMC (Fig. 8E)
or BMD (Fig. 8F). Taken together, these results suggest that in
bone, T1R2 activation may repress osteogenesis and stimulate
adipogenesis.
T1R3 KO animals have increased cortical area and
trabecular remodeling
To determine if effects of T1R2 deficiency on bone mass were
also observed in T1R3 KO mice, we independently evaluated
femurs of T1R3 KO mice on Western Diet for 24 weeks. T1R3
KO produced several pronounced changes in trabecular bone.
Trabecular BMD and tissue mineral density (TMD) were both
increased, as was the thickness of individual trabeculae (Fig. 9A),
although bone volume fraction and other variables were
unchanged (unpublished data). We also observed several signifi-
cant differences within cortical bone (Fig. 9B). Cortical area (left
panel) and cortical BMC (middle panel) were both increased, with
cortical BMD (right panel) unchanged. This increase in cortical
bone was reflected in the larger inner and outer cortical perimeter
in T1R3 KO mice (Fig. 9C, left and middle panel), and a larger
marrow area (Fig. 9C, right panel). These data, taken together
with increased bone mass in T1R2 KO animals, suggest that sweet
taste receptors may have a previously uncharacterized role in the
development and/or maintenance of adipose tissues and bone.
Discussion
In this manuscript, we present results demonstrating reduced
adiposity and smaller adipocytes in T1R3 and T1R2 KO animals
on Western diet. In support of a previously published report [14],
we also observed glucose intolerance in T1R3 KO mice compared
to controls. Although we not observe altered glucose homeostasis
in T1R2 KO mice on a western diet, the shorter duration of
dietary treatment in T1R2 KO animals (10 weeks for T1R2 versus
23 weeks for T1R3) may have contributed to this lack of effect. We
found no differences in any other measured metabolic parameters,
including circulating NEFA or random-fed glucose. Surprisingly,
we also observed that T1R2 and T1R3 KO mice have increased
bone mass, which is to our knowledge the first report of sweet taste
receptors having a role in bone or bone marrow biology.
The presence of an adipose tissue phenotype in T1R2 and
T1R3 KO animals suggests that these receptors may be involved
Figure 5. T1R2 KO mice have smaller adipocytes but equal adipocyte numbers. A) Adipocyte size frequency distribution in WT (n = 9) and
T1R2 KO (n= 9) mice on Western Diet for 14 weeks shows a greater prevalence of smaller adipocytes in T1R2 KO animals. B) T1R2 KO animals show a
decreased frequency of large adipocytes, defined as having a surface area greater than 7000 mm2, and increased frequency of small adipocytes,
defined as having a surface area smaller than 7000 mm2. Significance was determined using Student’s t-test. P ,0.05 indicated with #. Data are
expressed as mean plus S.D. C) Linear relationship between eWAT (epididymal white adipose tissue) weight and average adipocyte volume for WT
(r2 = 0.16) and T1R2 KO (r2 = 0.60) mice. Slope (P= 0.98) and intercept (P= 0.43)
doi:10.1371/journal.pone.0086454.g005
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in adipose biology in vivo. While the mechanism for reduced
adiposity and smaller adipocytes remains unclear, we can
speculate on the driving forces behind this phenotype. Smaller
adipocytes could be driven by alterations in lipolysis or lipid
storage, though circulating fasted NEFA is unchanged (Fig. 3G,
6F); however, this could be a subtle effect overcome by NEFA
uptake into liver and muscle. Sweet taste receptor ligands have
also been reported to suppress lipolysis [16], which would be
consistent with enhanced lipolytic activity in a taste receptor KO
model. However, these lipolytic effects in vitro are independent of
sweet taste receptor activity [16]. It is also unlikely that smaller
adipose depots are due to impaired adipogenesis, as adipocyte
number in epididymal fat depots was similar or even increased
between genotypes. In the absence of changes in food intake,
oxygen consumption, or physical activity, these results allow
speculation that sweet taste receptors could impact upon lipid
utilization, adipocyte expansion, or hormone secretion, and
thereby promote reduced adiposity. However, in the absence of
adipose tissue-specific sweet taste receptor KO animals, it remains
possible that sweet taste receptors impact adipose biology by acting
in other tissues, such as the gut or pancreas [11,13,14].
While both T1R2 and T1R3 KO animals have significantly
impaired sweet taste sensitivity, there has been some suggestion
that T1R2 and T1R3 may be capable of functioning indepen-
dently as homodimers [14,15,29]. Work from the Munger group
has suggested that T1R3, in particular, may be the primary
mediator of T1R2/T1R3 signaling [14,30]. The Shibata group
has corroborated this idea by suggesting that artificial sweeteners
regulate adipogenesis through T1R3, but not T1R2 [15].
However this work is in contrast to our own data, which showed
that effects of sweeteners on adipocyte differentiation and lipolysis
are independent of T1R2 and/or T1R3 [16]. Our observations
here that the loss of T1R2 largely phenocopies the loss of T1R3
suggests that the absence of either receptor is sufficient to impair
Figure 6. T1R2 KO mice do not have detectable changes in energy balance or glucose homeostasis. A) Blood glucose from WT (n= 9)
and T1R2 KO (n= 9) animals on Western Diet for 10 weeks following a 16 h fast. B) IP GTT in WT (n = 9) and T1R2 KO (n= 9) mice following 10 weeks
on Western Diet C) Serum insulin in WT (n = 9) and T1R2 KO (n= 9) animals 30 min following glucose injections of IP GTT. D) Random fed glucose from
WT (n= 9) and T1R2 KO (n= 9) animals following 14 weeks on Western Diet. E) Non-esterified fatty acids measured from serum of WT (n = 9) and T1R2
KO (n = 9) mice following 14 weeks on Western Diet. F) Non-esterified fatty acids measured from serum of WT (n = 9) and T1R2 KO (n= 9) mice on
Western Diet for 10 weeks following a 16 h fast. G) Respiratory Quotient (RQ) and H) total activity were measured on WT (n= 9) and T1R2 KO (n= 9)
mice in Comprehensive Laboratory Animal Monitoring System (CLAMS) cages after 3 weeks on Western Diet. I) Food intake in WT (n = 9) and T1R2 KO
(n = 9) animals on Western Diet measured over 5 weeks. Data are expressed as mean plus S.D
doi:10.1371/journal.pone.0086454.g006
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adipose tissue expansion. In particular, our observation that T1R2
KO animals have more extreme phenotypes in some cases, such as
in the loss of bone marrow adipocytes, suggests that the dominant
T1R3 activity observed by some groups is not a ubiquitous
phenomenon. However, metabolic phenotyping of T1R2/T1R3
double KO animals will need to be performed to definitively
address this possibility.
Reciprocal regulation of bone mass and bone marrow
adipocytes is an interesting finding of this study. While we cannot
interpret the loss of bone marrow adipocytes in T1R2 KO animals
as a failure of adipogenesis per se, the concurrent increase in bone
mass suggests taste receptor involvement in an osteogenesis-
adipogenesis developmental axis. There are currently few
connections in the literature between taste receptors or sweeteners
Figure 7. T1R2 KOmice have fewer bone marrow adipocytes. A) Adult WT (left panel) and T1R2 KO (right panel) mice were placed on Western
Diet for 14 wks, and bone marrow adipocytes were stained with osmium tetroxide before mCT scanning. Representative mCT shown, WT n= 9, T1R2
KO n=9. B) Quantification of osmium tetroxide staining in tibia marrow adipose tissue from WT and T1R2 KO mice on Western Diet for 14 weeks.
Data are expressed as mean plus S.D. C) Representative osmium tetroxide histology of bone marrow adipocytes in the proximal tibia. WT left panel,
T1R2 KO right panel. Significance was determined using an unpaired Student’s t-test. P ,0.01 indicated with ##.
doi:10.1371/journal.pone.0086454.g007
Figure 8. T1R2 KO animals have increased trabecular bone mineral content and cortical area. WT (n = 9) and T1R2 KO (n = 9) mice were
placed on Western Diet for 14 weeks, as in Fig 5. Trabecular (A,B,C) and cortical (D,E,F) parameters in tibia were evaluated by mCT. Significance was
determined using an unpaired Student’s t-test. P ,0.05 indicated with #, P-,0.01 indicated with ##, and P ,0.005 indicated with ###. Data are
expressed as mean plus S.D.
doi:10.1371/journal.pone.0086454.g008
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and bone mass. Aspartame treatment has been shown to delay the
onset of bone loss in rodents [31]; however the mechanism is likely
to be independent of sweet taste receptors. In a related study we
found that early exposure to saccharin increases bone mass later in
life (unpublished data). From this observation, we might predict
that T1R2 or T1R3 deficiency would result in a low bone mass
phenotype. However, our studies in vitro indicate that effects of
artificial sweeteners on adipocyte differentiation and metabolism
are independent of T1R2 or T1R3 activation [16], suggesting that
taste receptor KO models and artificial sweetener treatment
models are not necessarily reciprocal systems. Further studies will
be necessary to delineate taste receptor expression profiles in
osteoblasts and osteoclasts, and to evaluate the effects of sweet taste
receptor activation on bone development.
While there have been some reports of metabolic phenotypes in
taste receptor KO animals, these studies have primarily been
performed to characterize sweet taste receptor activity in the gut
and pancreas. In such studies, T1R3 KO mice have impaired
glucose tolerance in response to oral, but not intraperitoneal
GTTs [14]. This result emphasizes taste receptor-stimulated GLP-
1 secretion in the gut, rather than taste receptor-stimulated insulin
secretion in the pancreas, as a significant driver of glucose
homeostasis. However, an independent report shows that T1R2
expression is necessary for fructose-, but not glucose-stimulated
insulin secretion from the pancreas [13]. Taken together, these
results suggest that the sweet taste receptors of the gut and
pancreas may have differential impacts on glucose homeostasis
when presented with different ligands and/or diets. A similar
paradigm may affect adipose tissue, in which the availability of an
endogenous ligand may affect receptor activation and our
interpretation of the role of sweet taste receptors. Further studies
will be necessary to elucidate the identity of an endogenous ligand
for sweet taste receptors in vivo.
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